4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-20-061712
Director sold 33,750 shares at an average $151.32 ($5,107,148)
- Director acquired 33,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hindson Benjamin J. · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 1 in the form | +33,750 | $0.88 | $29,700 | 101,250 | D |
| 2020-12-01 | Sale : show line 2 in the form | −10,483 | $150.07 | $1,573,138 | 90,767 | D |
| 2020-12-01 | Sale : show line 3 in the form | −11,113 | $150.92 | $1,677,223 | 79,654 | D |
| 2020-12-01 | Sale : show line 4 in the form | −4,619 | $151.84 | $701,334 | 75,035 | D |
| 2020-12-01 | Sale : show line 5 in the form | −4,700 | $153.14 | $719,772 | 70,335 | D |
| 2020-12-01 | Sale : show line 6 in the form | −2,835 | $153.68 | $435,682 | 67,500 | D |
| Open-market sales · 33,750 sh · avg $151.32 · $5,107,148 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −33,750 | $0.88 | 2025-10-27 | 33,750 | 45,000 | D |
Loading xslF345X03/doc4.xml…